secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001104659-25-093891
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical extends term loan maturity to June 2028 and lowers revenue threshold for deferred repayment to $60M
--------------------------------------------------------------------------------

- Maturity of $25M Term Loan extended from Dec 27, 2027 to June 27, 2028.
- If trailing 12-month revenue > $60M as of Dec 31, 2025 (down from $70M), principal repayment deferred to Feb 2027.
- Without revenue trigger, quarterly repayment begins Feb 2026 at 7.5% of principal.
- With revenue trigger, quarterly repayment at 10% starting Feb 2027 (down from 15%).
- All $25M drawn; agreement amended with SWK Funding LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465925093891/0001104659-25-093891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465925093891/tm2527082d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-093891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer